Percentage of patients presenting with AJCC Stage Group 0, I, II, or III disease, who undergo a needle biopsy to establish diagnosis of breast cancer.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients who receive image or palpation-guided needle biopsy (core or FNA) for the diagnosis of breast cancer.
-
1.15 Denominator
Women with AJCC Stage 0, I, II, or II breast cancer undergoing surgery:
• Women
• Age >=18 at time of diagnosis
• Primary tumors of the breast
• Epithelial invasive malignancy only
• Diagnosis and all or part of first course of treatment performed at the reporting facility
-
Exclusions
Exclusions:
Men; not a first or only cancer diagnosis; non-epithelial tumors; metastatic disease (AJCC Stage IV); phyllodes tumor histology (9020);
Patient refused biopsy,
Patient medically unable to hold position for image guided biopsy,
Patient requires sub-arolar excision for nipple discharge,
Lesion too superficial,
Breast too small,
Lesion inaccessible by needle biopsy,
Cancer found in prophylactic mastectomy,
Benign high risk lesion diagnosed by needle biopsy, requiring excisional biopsy
Discordant biopsy results compared to suspicious imaging
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cancer Project 2015-2016Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization Email
-
-
-
Risk Adjustment
-